Evidence map›Paper›PMID 33076341›Full record

ArticleLife (Basel, Switzerland)2020

Clinical Evaluation of a Custom Gene Panel as a Tool for Precision Male Infertility Diagnosis by Next-Generation Sequencing.

Rossella Cannarella, Vincenza Precone, Giulia Guerri, Gian Maria Busetto, Gian Carlo Di Renzo, Sandro Gerli, Elena Manara, Astrit Dautaj, Matteo Bertelli, Aldo Eugenio Calogero

Open access · goldAbstract read
In one paragraph

Article in Life (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Is modified embryo transfer technique related to an increased pregnancy rate?Journal of the Chinese Medical Association : JCMA · 2021
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 1 country.

Rossella CannarellaDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.ORCID 0000-0003-4599-8487
Vincenza PreconeMAGI EUREGIO, 39100 Bolzano, Italy.
Giulia GuerriMAGI'S LAB, 38068 Rovereto, Italy.
Gian Maria BusettoDepartment of Urology, "Sapienza" University of Rome, Policlinico Umberto I, 00185 Rome, Italy.ORCID 0000-0002-7291-0316
Gian Carlo Di RenzoDepartment of Surgical and Biomedical Sciences, University of Perugia, 06123 Perugia, Italy.
Sandro GerliDepartment of Surgical and Biomedical Sciences, University of Perugia, 06123 Perugia, Italy.ORCID 0000-0003-1082-3062
Elena ManaraMAGI EUREGIO, 39100 Bolzano, Italy.ORCID 0000-0002-1176-3359
Astrit DautajEBTNA-LAB, Via delle Maioliche, 57/G, 38068 Rovereto, Italy.ORCID 0000-0002-6385-3444
Matteo BertelliMAGI EUREGIO, 39100 Bolzano, Italy.ORCID 0000-0002-9552-221X
Aldo Eugenio CalogeroDepartment of Clinical and Experimental Medicine, University of Catania, 95124 Catania, Italy.ORCID 0000-0001-6950-335X
Center for Neuroscience and Cognitive Systems · ITUniversity of Catania · ITUniversity of Perugia · ITPoliclinico Umberto I · IT

Funding

Provincia Autonoma di Trento dpg 1045/2017
6 · The paper itself

Abstract

backgroundUp to 15% of couples are infertile and male factor infertility accounts for approximately 50% of these cases. Male infertility is a multifactorial pathological condition. The genetic of male infertility is very complex and at least 2000 genes are involved in its etiology. Genetic testing by next-generation sequencing (NGS) technologies can be relevant for its diagnostic value in male infertile patients. Therefore, the aim of this study was to implement the diagnostic offer with the use of an NGS panel for the identification of genetic variants.

methodsWe developed an NGS gene panel that we used in 22 male infertile patients. The panel consisted of 110 genes exploring the genetic causes of male infertility; namely spermatogenesis failure due to single-gene mutations, central hypogonadism, androgen insensitivity syndrome, congenital hypopituitarism, and primary ciliary dyskinesia.

resultsNGS and a subsequent sequencing of the positive pathogenic or likely pathogenic variants, 5 patients (23%) were found to have a molecular defect. In particular, pathogenic variants were identified in

conclusionThis extended NGS-based diagnostic approach may represent a useful tool for the diagnosis of male infertility. The development of a custom-made gene panel by NGS seems capable of reducing the proportion of male idiopathic infertility.

Indexed as

defects of primary spermatogenesishypogonadotropic hypogonadismmale infertilityNGS diagnosisprimary ciliary dyskinesia

Identifiers

PMID33076341
PMCPMC7602585
OpenAlexW3093026732

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.